pharmaceutical
The $600 list price of the drug will remain the same, but the company said it would increase the maximum copay assistance program to $300 from $100.
Public health organizations are asking GOP Sen. Orrin Hatch why he seems so protective of pharmaceutical profits in Colombia.
The presidential hopeful is harder on Big Pharma than he is on Wall Street.
